Do the science writers and political reporters at the Associated Press ever compare notes? Based on their divergent coverage of stem cell research, it seems doubtful.
On Sunday, AP science writer Milan Rising reported that a Japanese scientist was under probable consideration to win this year's Nobel Prize in medicine:
A Japanese researcher who discovered how to make stem cells from ordinary skin cells and avoid the ethical quandaries of making them from human eggs could be a candidate for the medicine award when the 2010 Nobel Prize announcements kick off Monday, experts said.
Several prominent Nobel guessers have pointed to Kyoto University Professor Shinya Yamanaka as a potential winner of the coveted award.
Though the prize, announced this morning, went to another gentleman, the question remains: How could this be? As a court case over President Obama's executive order permitting federal funding of embryonic stem cell research has been progressing through its various appeals during the past several weeks, AP's political writers have been giving readers the clear impression that it is the research involving the destruction of human embryos that holds the real promise of scientific progress. Uh, not exactly. In fact, not at all.
A week ago, AP Science Writer Malcolm Ritter committed a serious act of journalism by telling readers what is really going on in stem cell science. It ought to be required reading for the Obama administration, which seems to be making a crusade out of human embryonic stem cell research (hESCR) while acting to stifle what appears to be significant progress in adult stem cell research (ASCR).
The amazing title of the AP reporter's article is "Adult stem cell research far ahead of embryonic." Given the establishment press's years-long favoritism towards hESCR going back at least to George W. Bush's 2001 announcement limiting federal government involvement in that area, it's enough to make you wonder if Ritter knew that his editors were on vacation or away on other business on August 2.